The clock is running out on Johnson & Johnson's efforts to stop the federal government from barring Medicare coverage of its implantable spinal disk, Charit√©.
Yesterday was the end of the 30-day comment period on the proposal to designate the device as not ''reasonable and necessary'' therapy for Medicare patients suffering from severe lower back pain. The stage is now set for a final ruling in mid-May.
